Appears on
Articles2
Understanding medicines access: a look at the severity modifier and its impact
In recent years, NICE has introduced a new way of deciding how much value to assign to some treatments, which is called the severity modifier. But what exactly is the severity modifier, and why is it important?
0
ABPI Blogs and News8d agoComparing new medicine availability across Europe
Each year, the European Pharmaceutical Industry Association (EFPIA) publishes data comparing the availability of new medicines across 36 European countries, as well as the average time it takes to make these new medicines accessible to patients. This article explains what the data shows and what it means for the UK.
0
ABPI Blogs and News5d ago